Physician profile
Christopher J Considine
NPI 1942299243
$2,136.26
in general payments reported to CMS, 2019-2025
7 companies · $490 in 2025
The $490 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2021: $135 · 2022: $161 · 2023: $414 · 2024: $513 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,416.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,535.21 | 2019-2025 | Augment Injectable, Variax, Fixos |
| Smith+Nephew, INC. | $196.01 | 2019-2022 | |
| Organogenesis INC. | $153.97 | 2019-2022 | |
| Treace Medical Concepts, INC. | $89.34 | 2023-2025 | |
| Osiris Therapeutics INC. | $79.25 | 2019 | |
| Depuy Synthes Sales INC. | $68.97 | 2023-2025 | Hammerlock, Motoband |
| Orthofix Medical, INC. | $13.51 | 2019-2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Considine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.